1. Home
  2. PBM vs SPRC Comparison

PBM vs SPRC Comparison

Compare PBM & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • SPRC
  • Stock Information
  • Founded
  • PBM 1994
  • SPRC 2004
  • Country
  • PBM Canada
  • SPRC Israel
  • Employees
  • PBM N/A
  • SPRC N/A
  • Industry
  • PBM
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBM
  • SPRC Health Care
  • Exchange
  • PBM NYSE
  • SPRC Nasdaq
  • Market Cap
  • PBM 3.5M
  • SPRC 3.4M
  • IPO Year
  • PBM N/A
  • SPRC N/A
  • Fundamental
  • Price
  • PBM $7.03
  • SPRC $6.69
  • Analyst Decision
  • PBM
  • SPRC
  • Analyst Count
  • PBM 0
  • SPRC 0
  • Target Price
  • PBM N/A
  • SPRC N/A
  • AVG Volume (30 Days)
  • PBM 86.1K
  • SPRC 34.8K
  • Earning Date
  • PBM 08-05-2025
  • SPRC 02-15-2025
  • Dividend Yield
  • PBM N/A
  • SPRC N/A
  • EPS Growth
  • PBM N/A
  • SPRC N/A
  • EPS
  • PBM 41.77
  • SPRC N/A
  • Revenue
  • PBM N/A
  • SPRC $1,306,000.00
  • Revenue This Year
  • PBM N/A
  • SPRC N/A
  • Revenue Next Year
  • PBM N/A
  • SPRC N/A
  • P/E Ratio
  • PBM $0.22
  • SPRC N/A
  • Revenue Growth
  • PBM N/A
  • SPRC N/A
  • 52 Week Low
  • PBM $2.93
  • SPRC $4.14
  • 52 Week High
  • PBM $402.00
  • SPRC $37.59
  • Technical
  • Relative Strength Index (RSI)
  • PBM 52.87
  • SPRC 43.92
  • Support Level
  • PBM $5.05
  • SPRC $7.37
  • Resistance Level
  • PBM $11.99
  • SPRC $8.48
  • Average True Range (ATR)
  • PBM 1.29
  • SPRC 0.63
  • MACD
  • PBM 0.34
  • SPRC -0.07
  • Stochastic Oscillator
  • PBM 30.67
  • SPRC 11.56

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: